CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 31 filers reported holding CORREVIO PHARMA CORP in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $35,000 | -30.0% | 91,405 | -25.1% | 0.00% | – |
| Q4 2019 | $50,000 | -59.7% | 122,061 | +97.2% | 0.00% | – |
| Q3 2019 | $124,000 | -31.1% | 61,892 | -25.6% | 0.00% | – |
| Q2 2019 | $180,000 | -73.1% | 83,190 | -60.8% | 0.00% | – |
| Q1 2019 | $670,000 | +477.6% | 212,263 | +355.5% | 0.00% | – |
| Q4 2018 | $116,000 | -84.8% | 46,600 | -75.4% | 0.00% | – |
| Q3 2018 | $761,000 | +489.9% | 189,366 | +455.0% | 0.00% | – |
| Q2 2018 | $129,000 | – | 34,122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|